| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +15% |
| 3Y CAGR | -3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| 3Y CAGR | +208% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹23,299.00 -71.00 (0.30%) | 29,919.11 | 60.11 | 15.97 | ||
PfizerPFIZER | ₹4,921.90 +122.60 (2.55%) | 21,962.57 | 29.87 | 5.23 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,574.90 +45.20 (1.79%) | 19,232.10 | 28.36 | 5.36 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,512.00 -133.00 (1.74%) | 19,124.63 | 112.75 | 21.91 |